Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: July 29, 2022 Report Code: GDME1410EPD-ST

Select Item

Incontinence devices are externally, or internally worn devices intended to protect the skin from the involuntary loss of urine. The incontinence devices pipeline market research report provides comprehensive information about the incontinence devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides key insights on major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Key Regions for the Incontinence Devices Pipeline Products Market

United States, Europe, the UK, Taiwan, India, Japan, Canada, Singapore, South Korea, and Australia have products in the pipeline. As of July 2022, the US has the highest number of products in the pipeline out of all these territories.

Incontinence Devices Pipeline Products Market, Regional Outlook

Incontinence Devices Pipeline Products Market, Regional Outlook

For more territorial insights, download a free report sample

Key Regulatory Paths for the Incontinence Devices Pipeline Products Market

The regulatory paths followed by the incontinence devices pipeline products include 510(k), CE, PMA, UKCA, de novo, HSA, MDL, MDITAC, BOPA, ICAC, Ninsho, and others. Most of the products follow the 510(k) pathway to enter the market.

Incontinence Devices Pipeline Products Market, by Regulatory Path

Incontinence Devices Pipeline Products Market, by Regulatory Path

For more regulatory path insights, download a free report sample

Key Segments in Incontinence Devices Pipeline Products Market

Urinary catheters, implanted electrical urinary continence device, foley catheters, external urinary catheters, nonimplanted electrical continence device, protective garments for incontinence, suprapubic catheters, and disposable protective garments are the key segments covered in the incontinence devices pipeline market research report. Urinary catheters hold the largest market share.

Incontinence Devices Pipeline Products Market, by Segments

Incontinence Devices Pipeline Products Market, by Segments

For more insights on key segments, download a free report sample

Key Companies in the Incontinence Devices Pipeline Products Market

Some of the key companies in the incontinence devices pipeline products market are 3D Urologic LLC Company, Affluent Medical SA Company, All India Institute of Medical Sciences, Amber Therapeutics Ltd Company, APRUS Bio-Medical Innovations Pvt Ltd, Xennovate Medical LLC Company, Watkins Conti Products Inc, among others.

Market Report Overview

Key Territories United States, Europe, the UK, Taiwan, India, Japan, Canada, Singapore, South Korea, and Australia
Key Regulatory Paths 510(k), CE, PMA, UKCA, de novo, HSA, MDL, MDITAC, BOPA, ICAC, Ninsho, and Others
Key Segments Urinary Catheters, Implanted Electrical Urinary Continence Device, Foley Catheters, External Urinary Catheters, Nonimplanted Electrical Continence Device, Protective Garments for Incontinence, Suprapubic Catheters, and Disposable Protective Garments
Key Companies D Urologic LLC Company, Affluent Medical SA Company, All India Institute of Medical Sciences, Amber Therapeutics Ltd Company, APRUS Bio-Medical Innovations Pvt Ltd, Xennovate Medical LLC Company, and Watkins Conti Products Inc

Scope

This report provides:

  • Extensive coverage of the incontinence devices under development
  • The report reviews details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of incontinence devices and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of incontinence devices under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3D Urologic LLC
Affluent Medical SA
All India Institute of Medical Sciences
Amber Therapeutics Ltd
APRUS Bio-Medical Innovations Pvt Ltd
Aran Biomedical
AugmentRx Medical Inc.
Aurie
Becton Dickinson and Co
Binding Sciences Ltd
Biocrede Inc
BioModics ApS
Bioring SA (Inactive)
Boston Children's Hospital
Boston Scientific Corp
Brighton Development LLC
Camstent Ltd
CathBuddy Inc
CELLF-Bio LLC
Ceragenix Pharmaceuticals, Inc. (Inactive)
Chain Antimicrobials Ltd
Collamedix Inc
Coloplast A/S
Continale Medical Pte Ltd
Continara Limited (Inactive)
Continental Dry-Works
Control Flo Medical LLC
ConvaTec Group Plc
Dongbang Medical Co Ltd
DUALIS MedTech GmbH
EchoScope Inc
Elidah, LLC
Endo International Plc
EndoStim Inc
Enox Biopharma Inc (Inactive)
Ergoresearch Ltd
Facet Technologies LLC
Fannin Partners LLC
Flat Medical Inc
FLEXIPROBE LTD.
Floelle Inc.
Flume Catheter Co Ltd
FocusStart LLC
Fuisz Pharma LLC
GT Urological LLC
Gweepi Medical Inc.
Gynamics Ltd
Implantica CE & Production Ltd
inContAlert
Ingenion Medical Ltd
InterVaal Pte Ltd
Invent Medic Sweden AB
Jabil Inc
Laborie Medical Technologies Inc
Leading Age Supplies LLC
Lilium Otsuka Co., Ltd.
MagCath ApS
Medici Medical Srl
Medi-Globe GmbH
Montana State University
MyoPowers Medical Technologies France SAS
N8 Medical LLC
Novuqare BV
Olympus Endo Technology America Inc
OTU Medical Inc
Pennsylvania State University
PetVivo Holdings Inc
PolyNovo Biomaterials Pty Ltd
Polytechnic University of Catalonia
Polytechnique Montreal
Precision Medical Devices Inc
Prosurg Inc
Provenmed
Pyriscence LLC
Quick-Med Technologies Inc
RegenMedTX LLC
Renovia Inc
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
Riocath Global AS
Salusion B.V.
Sharklet Technologies Inc
SmartWeave Inc
Smartz AG
Solace Therapeutics Inc
Stanford University
The Feinstein Institute for Medical Research
The University of Nottingham
Tractivus SL
University of Amsterdam
University of California San Diego
University of Michigan Pediatric Device Consortium
University of North Carolina
University of Saskatchewan
University of South Florida
University of Texas Health Science Center at San Antonio
University of Utah
Urinary BioSolutions LLC (Inactive)
UroDev Medical
Uromedica Inc
UroMems SAS
Urova Medical Inc.
Vesiflo, Inc.
Vysera Biomedical Ltd
Washington University in St Louis
Watkins Conti Products Inc
Xennovate Medical LLC

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 10

|1.2 List of Figures 17

2 Introduction 18

2.1 Incontinence Devices Overview 18

3 Products under Development 19

3.1 Incontinence Devices – Pipeline Products by Stage of Development 19

3.2 Incontinence Devices – Pipeline Products by Segment 20

3.3 Incontinence Devices – Pipeline Products by Territory 21

3.4 Incontinence Devices – Pipeline Products by Regulatory Path 22

3.5 Incontinence Devices – Pipeline Products by Estimated Approval Date 23

3.6 Incontinence Devices – Ongoing Clinical Trials 24

4 Incontinence Devices – Pipeline Products under Development by Companies 25

4.1 Incontinence Devices Companies – Pipeline Products by Stage of Development 25

4.2 Incontinence Devices – Pipeline Products by Stage of Development 29

5 Incontinence Devices Companies and Product Overview 32

5.1 3D Urologic LLC Company Overview 32

5.1.1 3D Urologic LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.2 Affluent Medical SA Company Overview 33

5.2.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 33

5.3 All India Institute of Medical Sciences Company Overview 36

5.3.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 36

5.4 Amber Therapeutics Ltd Company Overview 37

5.4.1 Amber Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.5 APRUS Bio-Medical Innovations Pvt Ltd Company Overview 40

5.5.1 APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.6 Aran Biomedical Company Overview 42

5.6.1 Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview 42

5.7 AugmentRx Medical Inc. Company Overview 43

5.7.1 AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

5.8 Aurie Company Overview 44

5.8.1 Aurie Pipeline Products & Ongoing Clinical Trials Overview 44

5.9 Becton Dickinson and Co Company Overview 45

5.9.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 45

5.10 Binding Sciences Ltd Company Overview 46

5.10.1 Binding Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.11 Biocrede Inc Company Overview 49

5.11.1 Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.12 BioModics ApS Company Overview 50

5.12.1 BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 50

5.13 Bioring SA (Inactive) Company Overview 51

5.13.1 Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51

5.14 Boston Children’s Hospital Company Overview 52

5.14.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 52

5.15 Boston Scientific Corp Company Overview 54

5.15.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 54

5.16 Brighton Development LLC Company Overview 56

5.16.1 Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.17 Camstent Ltd Company Overview 57

5.17.1 Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.18 CathBuddy Inc Company Overview 60

5.18.1 CathBuddy Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.19 CELLF-Bio LLC Company Overview 61

5.19.1 CELLF-Bio LLC Pipeline Products & Ongoing Clinical Trials Overview 61

5.20 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 62

5.20.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

5.21 Chain Antimicrobials Ltd Company Overview 63

5.21.1 Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.22 Collamedix Inc Company Overview 64

5.22.1 Collamedix Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.23 Coloplast A/S Company Overview 65

5.23.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 65

5.24 Continale Medical Pte Ltd Company Overview 66

5.24.1 Continale Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.25 Continara Limited (Inactive) Company Overview 67

5.25.1 Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67

5.26 Continental Dry-Works Company Overview 68

5.26.1 Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 68

5.27 Control Flo Medical LLC Company Overview 69

5.27.1 Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 69

5.28 ConvaTec Group Plc Company Overview 70

5.28.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 70

5.29 Dongbang Medical Co Ltd Company Overview 71

5.29.1 Dongbang Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

5.30 DUALIS MedTech GmbH Company Overview 72

5.30.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 72

5.31 EchoScope Inc Company Overview 73

5.31.1 EchoScope Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.32 Elidah, LLC Company Overview 74

5.32.1 Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 74

5.33 Endo International Plc Company Overview 75

5.33.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 75

5.34 EndoStim Inc Company Overview 77

5.34.1 EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.35 Enox Biopharma Inc (Inactive) Company Overview 78

5.35.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

5.36 Ergoresearch Ltd Company Overview 79

5.36.1 Ergoresearch Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.37 Facet Technologies LLC Company Overview 80

5.37.1 Facet Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 80

5.38 Fannin Partners LLC Company Overview 81

5.38.1 Fannin Partners LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.39 Flat Medical Inc Company Overview 82

5.39.1 Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.40 FLEXIPROBE LTD. Company Overview 84

5.40.1 FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 84

5.41 Floelle Inc. Company Overview 85

5.41.1 Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 85

5.42 Flume Catheter Co Ltd Company Overview 86

5.42.1 Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 86

5.43 FocusStart LLC Company Overview 89

5.43.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 89

5.44 Fuisz Pharma LLC Company Overview 90

5.44.1 Fuisz Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 90

5.45 GT Urological LLC Company Overview 91

5.45.1 GT Urological LLC Pipeline Products & Ongoing Clinical Trials Overview 91

5.46 Gweepi Medical Inc. Company Overview 92

5.46.1 Gweepi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 92

5.47 Gynamics Ltd Company Overview 93

5.47.1 Gynamics Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.48 Implantica CE & Production Ltd Company Overview 94

5.48.1 Implantica CE & Production Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

5.49 inContAlert Company Overview 96

5.49.1 inContAlert Pipeline Products & Ongoing Clinical Trials Overview 96

5.50 Ingenion Medical Ltd Company Overview 97

5.50.1 Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

5.51 InterVaal Pte Ltd Company Overview 99

5.51.1 InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

5.52 Invent Medic Sweden AB Company Overview 100

5.52.1 Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 100

5.53 Jabil Inc Company Overview 101

5.53.1 Jabil Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.54 Laborie Medical Technologies Inc Company Overview 102

5.54.1 Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 102

5.55 Leading Age Supplies LLC Company Overview 104

5.55.1 Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 104

5.56 Lilium Otsuka Co., Ltd. Company Overview 105

5.56.1 Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 105

5.57 MagCath ApS Company Overview 106

5.57.1 MagCath ApS Pipeline Products & Ongoing Clinical Trials Overview 106

5.58 Medici Medical Srl Company Overview 107

5.58.1 Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 107

5.59 Medi-Globe GmbH Company Overview 108

5.59.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 108

5.60 Montana State University Company Overview 109

5.60.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 109

5.61 MyoPowers Medical Technologies France SAS Company Overview 110

5.61.1 MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 110

5.62 N8 Medical LLC Company Overview 111

5.62.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 111

5.63 Novuqare BV Company Overview 112

5.63.1 Novuqare BV Pipeline Products & Ongoing Clinical Trials Overview 112

5.64 Olympus Endo Technology America Inc Company Overview 113

5.64.1 Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.65 OTU Medical Inc Company Overview 114

5.65.1 OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.66 Pennsylvania State University Company Overview 117

5.66.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 117

5.67 PetVivo Holdings Inc Company Overview 118

5.67.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.68 PolyNovo Biomaterials Pty Ltd Company Overview 119

5.68.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

5.69 Polytechnic University of Catalonia Company Overview 120

5.69.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 120

5.70 Polytechnique Montreal Company Overview 122

5.70.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview 122

5.71 Precision Medical Devices Inc Company Overview 123

5.71.1 Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 123

5.72 Prosurg Inc Company Overview 124

5.72.1 Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.73 Provenmed Company Overview 125

5.73.1 Provenmed Pipeline Products & Ongoing Clinical Trials Overview 125

5.74 Pyriscence LLC Company Overview 126

5.74.1 Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 126

5.75 Quick-Med Technologies Inc Company Overview 127

5.75.1 Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 127

5.76 RegenMedTX LLC Company Overview 128

5.76.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 128

5.77 Renovia Inc Company Overview 129

5.77.1 Renovia Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.78 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 130

5.78.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 130

5.79 Riocath Global AS Company Overview 131

5.79.1 Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 131

5.80 Salusion B.V. Company Overview 136

5.80.1 Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 136

5.81 Sharklet Technologies Inc Company Overview 137

5.81.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 137

5.82 SmartWeave Inc Company Overview 138

5.82.1 SmartWeave Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.83 Smartz AG Company Overview 139

5.83.1 Smartz AG Pipeline Products & Ongoing Clinical Trials Overview 139

5.84 Solace Therapeutics Inc Company Overview 140

5.84.1 Solace Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.85 Stanford University Company Overview 141

5.85.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 141

5.86 The Feinstein Institute for Medical Research Company Overview 142

5.86.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 142

5.87 The University of Nottingham Company Overview 143

5.87.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 143

5.88 Tractivus SL Company Overview 144

5.88.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 144

5.89 University of Amsterdam Company Overview 145

5.89.1 University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 145

5.90 University of California San Diego Company Overview 146

5.90.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 146

5.91 University of Michigan Pediatric Device Consortium Company Overview 147

5.91.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 147

5.92 University of North Carolina Company Overview 148

5.92.1 University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview 148

5.93 University of Saskatchewan Company Overview 149

5.93.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 149

5.94 University of South Florida Company Overview 150

5.94.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 150

5.95 University of Texas Health Science Center at San Antonio Company Overview 152

5.95.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 152

5.96 University of Utah Company Overview 153

5.96.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 153

5.97 Urinary BioSolutions LLC (Inactive) Company Overview 155

5.97.1 Urinary BioSolutions LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 155

5.98 UroDev Medical Company Overview 156

5.98.1 UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 156

5.99 Uromedica Inc Company Overview 159

5.99.1 Uromedica Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.100 UroMems SAS Company Overview 162

5.100.1 UroMems SAS Pipeline Products & Ongoing Clinical Trials Overview 162

5.101 Urova Medical Inc. Company Overview 163

5.101.1 Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 163

5.102 Vesiflo, Inc. Company Overview 164

5.102.1 Vesiflo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164

5.103 Vysera Biomedical Ltd Company Overview 165

5.103.1 Vysera Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 165

5.104 Washington University in St Louis Company Overview 166

5.104.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 166

5.105 Watkins Conti Products Inc Company Overview 167

5.105.1 Watkins Conti Products Inc Pipeline Products & Ongoing Clinical Trials Overview 167

5.106 Xennovate Medical LLC Company Overview 170

5.106.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 170

6 Incontinence Devices- Recent Developments 171

6.1 Jul 12, 2022: Owens & Minor Elects Carissa Rollins to Board of Directors 171

6.2 Jul 11, 2022: Zynex Reports Preliminary Second Quarter 2022 Results and Reiterates Full Year Revenue and Ebitda Guidance 171

6.3 Jul 11, 2022: Affluent Medical appoints Dr. Christophe Giot Vice President Clinical Affairs 172

6.4 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 172

6.5 Jun 24, 2022: Ontex Announces Details for its Q2 and H1 2022 Results Publication and Publishes Additional Restated 2021 Income Statement Data 172

6.6 Jun 13, 2022: Hollister receives vizient contract for Urological Products 173

6.7 Jun 07, 2022: Teleflex launches new arrow pressure injectable midline catheter in Europe, the Middle East and Africa region 173

6.8 Jun 06, 2022: Shandong Weigao Group Medical Polymer Announce annual general meeting results 174

6.9 Jun 03, 2022: Merz Aesthetics presents data at the IMCAS World Congress 2022 175

6.10 Jun 02, 2022: Adapthealth to Participate in Jefferies Healthcare Conference 176

6.11 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 176

6.12 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 177

6.13 May 18, 2022: Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq 177

6.14 May 11, 2022: Coloplast announces the successful issuance of EUR

2.2 billion senior notes under its Euro Medium Term Note programme 177

6.15 May 11, 2022: Unicharm announces The first quarter report for the fiscal year ending December 2022 has been posted 178

6.16 May 10, 2022: Zynex Medical to Participate in Upcoming Investor Conferences 179

6.17 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022 179

6.18 May 03, 2022: Owens & Minor Reports First Quarter 2022 Financial Results 179

6.19 May 02, 2022: Teleflex to Host Analyst & Investor Day on May 20, 2022 181

6.20 Apr 29, 2022: HARTMANN starts 1st quarter with lower earnings 181

6.21 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 182

6.22 Apr 28, 2022: Teleflex Reports First Quarter Financial Results And Full Year Outlook 182

6.23 Apr 28, 2022: Zynex Announces 2022 First Quarter Earnings 184

6.24 Apr 27, 2022: Bactiguard Holding : Interim report for first quarter 2022 185

6.25 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022 187

6.26 Apr 22, 2022: Shandong Weigao Group Medical Polymer Co. Announces Management Changes 189

6.27 Apr 18, 2022: Zynex to Announce First Quarter 2022 Financial Results 194

6.28 Apr 15, 2022: Shandong Weigao Group Medical Polymer Co. Announces Results for the Year Ended 31 December 2021 194

6.29 Apr 04, 2022: Ontex publishes integrated annual report 2021 and convenes annual shareholders’ meeting on May 5 194

6.30 Mar 30, 2022: ConvaTec Group announces Annual Report and Accounts 2021 and Notice of AGM 195

6.31 Mar 29, 2022: Bactiguard Holding Notice to attend the Annual General Meeting 195

6.32 Mar 24, 2022: INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society Annual Meeting 199

6.33 Mar 24, 2022: Shandong Weigao Group Medical Polymer Annual Results Announcement For the Year Ended 31 December and Date of Board Meeting 199

6.34 Mar 21, 2022: Bactiguard appoints Carin Jakobson as new CFO 200

6.35 Mar 17, 2022: ConvaTec Group Announces Board Change 200

6.36 Mar 09, 2022: Owens & Minor to Present at the Barclays Global Healthcare Conference Tuesday, March 15, 2022 200

6.37 Mar 08, 2022: ConvaTec Group Annual Results for the twelve months ended 31 December 2021 200

6.38 Mar 08, 2022: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2021 202

6.39 Mar 03, 2022: CooperCompanies Announces First Quarter 2022 Results 205

6.40 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 206

6.41 Feb 23, 2022: Shandong Weigao Orthopaedic Device announce preliminary results for the year ended 31 december 2021 208

6.42 Feb 16, 2022: Raumedic appoints new CEO at its U.S. headquarters 208

6.43 Feb 15, 2022: Unicharm Announce Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 209

6.44 Feb 08, 2022: JMS Announces Financial Results for the 3rd Quarter of FYE March 2022 212

6.45 Feb 08, 2022: Zynex to Announce Fourth Quarter 2021 Financial Results 214

6.46 Feb 08, 2022: Bactiguard presents focused growth strategy and sets new long-term financial targets 214

6.47 Jan 31, 2022: Poly Medicure Announces Unaudited Financial Results for the Quarter and Nine Month Ended December 31 2021 215

6.48 Jan 31, 2022: Poly Medicure Announces Statement of Unaudited Standalone Financial Results for the Quarter and Nine Months Ended December 31 2021 216

6.49 Jan 27, 2022: Cooper Companies Announces Release Date for First Quarter 2022 217

6.50 Jan 27, 2022: ConvaTec Group Announce Board Committee Changes 217

6.51 Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company’s director and board secretary 218

6.52 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 218

6.53 Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company 218

6.54 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021 218

6.55 Dec 09, 2021: Convatec Announces Chief Financial Officer succession 220

6.56 Dec 08, 2021: Shandong Weigao Group Medical Polymer Co. Notice of Extraordinary General Meeting 221

6.57 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE 221

6.58 Dec 02, 2021: Coloplast Announcement no. 11/2021 Decisions at the Annual General Meeting 2021 221

6.59 Nov 29, 2021: Owens & Minor to Present at Bank of America Leveraged Finance Conference 222

6.60 Nov 24, 2021: Zynex to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference 222

6.61 Nov 18, 2021: Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference 222

6.62 Nov 17, 2021: Springfield Memorial Hospital partners with Medline to improve operating room efficiencies and outcomes 223

6.63 Nov 12, 2021: Centenial Surgical Suture Announces Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021 224

6.64 Nov 12, 2021: Centenial Surgical Suture Announces Change in Directorate 224

6.65 Nov 09, 2021: Coloplast Notice of Annual General Meeting 224

6.66 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 224

6.67 Nov 05, 2021: Unicharm Corp. Announces Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2021 225

6.68 Nov 05, 2021: JMS Announces Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2022 225

6.69 Nov 04, 2021: Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance 227

6.70 Nov 02, 2021: CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2021 228

6.71 Nov 02, 2021: Zynex Announces 2021 Third Quarter Earnings 229

6.72 Nov 01, 2021: Coloplast Announces Full-year Financial Results 2020/21 230

6.73 Nov 01, 2021: Coloplast delivers solid full year results in line with the company’s financial guidance after a strong Q4 performance 231

6.74 Nov 01, 2021: Poly Medicure announces Unaudited Financial Results Standalone & Consolidated for the Second quarter and half year ended on 30th September 2021 232

6.75 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER 233

6.76 Oct 28, 2021: Teleflex Reports Third Quarter 2021 Results and Full Year Outlook 243

6.77 Oct 28, 2021: Bactiguard Holding Announces Interim report for Q3 2021 247

6.78 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 249

6.79 Oct 25, 2021: Zynex Schedules 2021 Third Quarter Earnings Call 254

6.80 Oct 21, 2021: Owens & Minor will Report Third Quarter Financial Results on Wednesday, November 3, 2021 254

6.81 Oct 14, 2021: Teleflex Announces Third Quarter 2021 Earnings Conference Call Information 254

6.82 Sep 23, 2021: Dentsply Sirona announces a comprehensive restage of its implant business 254

6.83 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 255

6.84 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference 256

6.85 Sep 01, 2021: Shandong Weigao Group Medical Polymer Notice of Extraordinary General Meeting and Proposed Interim Dividend 256

6.86 Aug 31, 2021: Bactiguard recruits Chief Licensing Officer to accelerate growth 256

6.87 Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results 256

6.88 Aug 27, 2021: Shandong Weigao Group Medical Polymer Announcement of Interim Results for the Six Months Ended 30 June 2021 258

6.89 Aug 27, 2021: Shandong Weigao Group Announces Interim Results for the Six Months Ended 30 June 2021 258

6.90 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference 258

6.91 Aug 18, 2021: Coloplast delivers 11% organic growth in Q3 and an EBIT margin of 33% 258

6.92 Aug 11, 2021: Hartmann’s announce Sales and earnings under pressure 260

6.93 Aug 10, 2021: Sientra Reports Record Breast Products Revenue for Second Quarter 2021, Raises Revenue Guidance for Full Year 2021 260

6.94 Aug 06, 2021: Strides inks definitive agreement with Endo to acquire its manufacturing facility in the US along with basket of ANDAs 262

6.95 Aug 06, 2021: JMS Announces Financial Results for the First Quarter of Fiscal Year Ending March 31, 2022 263

6.96 Aug 05, 2021: Endo International Reports Second-Quarter 2021 Financial Results 263

6.97 Aug 05, 2021: INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021 264

6.98 Aug 04, 2021: Unicharm announces summary of financial results for Q2 of fiscal year ending December 31, 2021 265

6.99 Aug 04, 2021: Unicharm Announces Consolidated Financial Results for the Second Quarter of Fiscal Year Ending December 31, 2021 265

6.100 Jul 30, 2021: ConvaTec Group Announces Interim Results for the six months ended 30 June 2021 268

6.101 Jul 29, 2021: Ontex Group reports results for six months ending June 30, 2021 269

6.102 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021 269

6.103 Jul 29, 2021: Zynex Announces 2021 Second Quarter Earnings 270

6.104 Jul 29, 2021: CooperCompanies Announces Release Date for Third Quarter 2021 271

6.105 Jul 29, 2021: Poly Medicure announce Unaudited Quarterly Financial Results(Standalone & Consolidated) For The Quarter Ended

30.06.2021 271

6.106 Jul 29, 2021: Poly Medicure Announces Un-Audited Financial Results for the First Quarter ended on 30th June 2021 272

7 Appendix 273

7.1 Methodology 273

7.2 About GlobalData 276

7.3 Contact Us 276

7.4 Disclaimer 276

Table

Incontinence Devices – Pipeline Products by Stage of Development 19

Incontinence Devices – Pipeline Products by Segment 20

Incontinence Devices – Pipeline Products by Territory 21

Incontinence Devices – Pipeline Products by Regulatory Path 22

Incontinence Devices – Pipeline Products by Estimated Approval Date 23

Incontinence Devices – Ongoing Clinical Trials 24

Incontinence Devices Companies – Pipeline Products by Stage of Development 25

Incontinence Devices – Pipeline Products by Stage of Development 29

3D Urologic LLC Pipeline Products & Ongoing Clinical Trials Overview 32

3D Urologic Device – Product Status 32

3D Urologic Device – Product Description 32

Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 33

Artus – Product Status 33

Artus – Product Description 33

Affluent Medical SA – Ongoing Clinical Trials Overview 34

Artus – Safety and Clinical Performance Study of the ARTUS MONO Artificial Urinary Sphincter (AUS) for the Treatment of Stress Urinary Incontinence (SUI) Due to Intrinsic Sphincter Deficiency 35

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 36

Super Hydrophobic Catheter – Product Status 36

Super Hydrophobic Catheter – Product Description 36

Amber Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Amber-UI Bioelectronic System – Product Status 37

Amber-UI Bioelectronic System – Product Description 37

Amber Therapeutics Ltd – Ongoing Clinical Trials Overview 38

Amber-UI Bioelectronic System – Electrophysiological Studies of the Human Pudendal Nerve Using Short-duration Extracorporeal Stimulation 39

APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Incontinence Device – Adults – Product Status 40

Incontinence Device – Adults – Product Description 40

Incontinence Device – Children – Product Status 41

Incontinence Device – Children – Product Description 41

Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview 42

Biomaterial-Based Incontinence Device – Product Status 42

Biomaterial-Based Incontinence Device – Product Description 42

AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

SOLVE – Product Status 43

SOLVE – Product Description 43

Aurie Pipeline Products & Ongoing Clinical Trials Overview 44

Reusable Intermittent Catheter System – Product Status 44

Reusable Intermittent Catheter System – Product Description 44

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 45

NG Purewick Male External Cath – Product Status 45

NG Purewick Male External Cath – Product Description 45

Binding Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

RS – WP06 – Product Status 46

RS – WP06 – Product Description 46

Binding Sciences Ltd – Ongoing Clinical Trials Overview 47

RS – WP06 – An Evaluation of the Usability and Efficacy of a Prototype Handheld Urinal for Adults Who Suffer from Nocturia, Urge, Frequency, and/or Functional Incontinence 48

Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Urinary Catheter – Product Status 49

Urinary Catheter – Product Description 49

BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 50

Indwelling Urinary Catheter – Product Status 50

Indwelling Urinary Catheter – Product Description 50

Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51

Biowing – Product Status 51

Biowing – Product Description 51

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 52

Artificial Urinary Sphincter – Product Status 52

Artificial Urinary Sphincter – Product Description 52

PFMT Device – Product Status 53

PFMT Device – Product Description 53

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 54

Pathfinder RP – Product Status 54

Pathfinder RP – Product Description 54

Pathfinder TOT – Product Status 55

Pathfinder TOT – Product Description 55

Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 56

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Status 56

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Description 56

Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

Camstent Coated Foley Catheter – Product Status 57

Camstent Coated Foley Catheter – Product Description 57

Camstent Ltd – Ongoing Clinical Trials Overview 58

Camstent Coated Foley Catheter – ‘A Pilot Study to Assess the Impact of a Camstent Coated Catheter on Clinical Bacteriuria’ 59

Camstent Coated Foley Catheter – A Prospective Multicentre Randomized Study to Assess the Impact of a Catheter Coating on Clinical Bacteriuria 59

CathBuddy Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Urinary Catheterization System – Product Status 60

Urinary Catheterization System – Product Description 60

CELLF-Bio LLC Pipeline Products & Ongoing Clinical Trials Overview 61

Urinary Incontinence Device – Product Status 61

Urinary Incontinence Device – Product Description 61

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

Cerashield Coated Silicone Urinary Catheter – Product Status 62

Cerashield Coated Silicone Urinary Catheter – Product Description 62

Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Peptide-Coated Catheter – Product Status 63

Peptide-Coated Catheter – Product Description 63

Collamedix Inc Pipeline Products & Ongoing Clinical Trials Overview 64

CollaSling – Product Status 64

CollaSling – Product Description 64

Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 65

Urinary Incontinence Catheter – Product Status 65

Urinary Incontinence Catheter – Product Description 65

Continale Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Stress Urinary Incontinence Device – Product Status 66

Stress Urinary Incontinence Device – Product Description 66

Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67

UTROL Bionic Sphincter – Product Status 67

UTROL Bionic Sphincter – Product Description 67

Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 68

The Pocket – Product Status 68

The Pocket – Product Description 68

Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 69

ResQ Urological Catheter System – Product Status 69

ResQ Urological Catheter System – Product Description 69

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 70

GentleCath Compact Catheter – Product Status 70

GentleCath Compact Catheter – Product Description 70

Dongbang Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

Incontinence Sling Kit – Product Status 71

Incontinence Sling Kit – Product Description 71

DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 72

Implantable Wireless Sphincter System – Product Status 72

Implantable Wireless Sphincter System – Product Description 72

EchoScope Inc Pipeline Products & Ongoing Clinical Trials Overview 73

EchoScope Device – Product Status 73

EchoScope Device – Product Description 73

Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 74

Edytone – Product Status 74

Edytone – Product Description 74

Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 75

TOPAS Sling System – Product Status 75

TOPAS Sling System – Product Description 76

EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Implantable Device – Urinary Incontinence – Product Status 77

Implantable Device – Urinary Incontinence – Product Description 77

Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

Self-Sterilizing Urinary Catheter – Product Status 78

Self-Sterilizing Urinary Catheter – Product Description 78

Ergoresearch Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Urinary Disorders Implant – Product Status 79

Urinary Disorders Implant – Product Description 79

Facet Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 80

Periurethral Device – Product Status 80

Periurethral Device – Product Description 80

Fannin Partners LLC Pipeline Products & Ongoing Clinical Trials Overview 81

Securine Device – Product Status 81

Securine Device – Product Description 81

Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 82

UroAid – F – Product Status 82

UroAid – F – Product Description 82

UroAid – IV – Product Status 83

UroAid – IV – Product Description 83

FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 84

Flexiprobe Device – Product Status 84

Flexiprobe Device – Product Description 84

Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 85

Floelle Device – Product Status 85

Floelle Device – Product Description 85

Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 86

Flume Catheter – Product Status 86

Flume Catheter – Product Description 86

Flume Catheter Co Ltd – Ongoing Clinical Trials Overview 87

Flume Catheter – A New Urinary Catheter Designed to Improve Bladder Drainage: First-in-human Testing of the Flume Catheter. Version 1.0 88

FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 89

Anti-biofilm Urological Catheter – Product Status 89

Anti-biofilm Urological Catheter – Product Description 89

Fuisz Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 90

Fuisz Device – Product Status 90

Fuisz Device – Product Description 90

GT Urological LLC Pipeline Products & Ongoing Clinical Trials Overview 91

Implantable Incontinence Device – Product Status 91

Implantable Incontinence Device – Product Description 91

Gweepi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 92

SmartBrief System – Product Status 92

SmartBrief System – Product Description 92

Gynamics Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

Nolix – Product Status 93

Nolix – Product Description 93

Implantica CE & Production Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

UriControl – Product Status 94

UriControl – Product Description 94

UriRestore – Product Status 95

UriRestore – Product Description 95

inContAlert Pipeline Products & Ongoing Clinical Trials Overview 96

Advanced Wearable Sensor – Product Status 96

Advanced Wearable Sensor – Product Description 96

Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

CymActive SealSoft Bladder Management System – Product Status 97

CymActive SealSoft Bladder Management System – Product Description 97

FemActive Catheter – Product Status 98

FemActive Catheter – Product Description 98

InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

InterVaal Catheter – Product Status 99

InterVaal Catheter – Product Description 99

Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 100

Efemia Bladder Support – Product Status 100

Efemia Bladder Support – Product Description 100

Jabil Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Shakoori Relief Valve – Product Status 101

Shakoori Relief Valve – Product Description 101

Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 102

G2 Urostym – Product Status 102

G2 Urostym – Product Description 102

T-DOC 5Fr Air-Charged Catheter – Product Status 103

T-DOC 5Fr Air-Charged Catheter – Product Description 103

Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 104

Urinary Catheter – Product Status 104

Urinary Catheter – Product Description 104

Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 105

Next Gen Yuririn USH-052 Scanner – Product Status 105

Next Gen Yuririn USH-052 Scanner – Product Description 105

MagCath ApS Pipeline Products & Ongoing Clinical Trials Overview 106

Obtinu Device – Product Status 106

Obtinu Device – Product Description 106

Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 107

Time-Delayed Valve System – Product Status 107

Time-Delayed Valve System – Product Description 107

Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 108

Incontinence Prosthesis – Product Status 108

Incontinence Prosthesis – Product Description 108

Montana State University Pipeline Products & Ongoing Clinical Trials Overview 109

Safety Adaptor For Foley Catheter – Product Status 109

Safety Adaptor For Foley Catheter – Product Description 109

MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 110

ARTUS MONO – Product Status 110

ARTUS MONO – Product Description 110

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 111

CeraShield Urinary Catheter – Product Status 111

CeraShield Urinary Catheter – Product Description 111

Novuqare BV Pipeline Products & Ongoing Clinical Trials Overview 112

MAXAM Pelvic Floor Device – Product Status 112

MAXAM Pelvic Floor Device – Product Description 112

Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 113

Uro-Ease – Product Status 113

Uro-Ease – Product Description 113

OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 114

NextGen Purewick – Product Status 114

NextGen Purewick – Product Description 114

Portable Purewick – Product Status 115

Portable Purewick – Product Description 115

Purewick No Touch – Product Status 115

Purewick No Touch – Product Description 116

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 117

Smart Wrap – Product Status 117

Smart Wrap – Product Description 117

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 118

Female Urinary Incontinence Device – Product Status 118

Female Urinary Incontinence Device – Product Description 118

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

Novosorb – Bladder Sling – Product Status 119

Novosorb – Bladder Sling – Product Description 119

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 120

Biofeedback System – Urinary Incontinence – Product Status 120

Biofeedback System – Urinary Incontinence – Product Description 121

Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview 122

Bladder Implant – Product Status 122

Bladder Implant – Product Description 122

Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 123

Politano-Sayet-Sutherland Flow Control Device – Product Status 123

Politano-Sayet-Sutherland Flow Control Device – Product Description 123

Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 124

ConstrictX – Product Status 124

ConstrictX – Product Description 124

Provenmed Pipeline Products & Ongoing Clinical Trials Overview 125

ActivGo Kit – Product Status 125

ActivGo Kit – Product Description 125

Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 126

Anti-Microbial Catheter – Product Status 126

Anti-Microbial Catheter – Product Description 126

Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 127

Incontinence Device – Product Status 127

Incontinence Device – Product Description 127

RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 128

Neo Bladder Augment – Urge Incontinence – Product Status 128

Neo Bladder Augment – Urge Incontinence – Product Description 128

Renovia Inc Pipeline Products & Ongoing Clinical Trials Overview 129

Leva – Chronic Fecal Incontinence – Product Status 129

Leva – Chronic Fecal Incontinence – Product Description 129

Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 130

Permanent Urinary Catheter Shutter – Product Status 130

Permanent Urinary Catheter Shutter – Product Description 130

Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 131

Epicystostomy Catheter – Product Status 131

Epicystostomy Catheter – Product Description 131

Female Urinary Catheter Permanent – Product Status 132

Female Urinary Catheter Permanent – Product Description 132

Female Urinary Catheter Simple – Product Status 132

Female Urinary Catheter Simple – Product Description 133

Female Urinary Catheter With Insertion Tool – Product Status 133

Female Urinary Catheter With Insertion Tool – Product Description 133

Male Urinary Catheter Permanent – Product Status 134

Male Urinary Catheter Permanent – Product Description 134

Male Urinary Catheter With Insertion Tool – Product Status 134

Male Urinary Catheter With Insertion Tool – Product Description 135

Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 136

Home Care Incontinence Device – Product Status 136

Home Care Incontinence Device – Product Description 136

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 137

Foley Urinary Catheter – Product Status 137

Foley Urinary Catheter – Product Description 137

SmartWeave Inc Pipeline Products & Ongoing Clinical Trials Overview 138

Mesh Sling – Product Status 138

Mesh Sling – Product Description 138

Smartz AG Pipeline Products & Ongoing Clinical Trials Overview 139

Smart Diaper Sensor – Product Status 139

Smart Diaper Sensor – Product Description 139

Solace Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 140

Vesair Bladder Control System – Product Status 140

Vesair Bladder Control System – Product Description 140

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 141

OTC Device – Stress Urinary Incontinence – Product Status 141

OTC Device – Stress Urinary Incontinence – Product Description 141

The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 142

Confidence Building Incontinence Pad – Product Status 142

Confidence Building Incontinence Pad – Product Description 142

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 143

Antimicrobial Catheter – Product Status 143

Antimicrobial Catheter – Product Description 143

Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 144

UroPHOB urinary catheter – Product Status 144

UroPHOB urinary catheter – Product Description 144

University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 145

Percutaneous Nephrostomy Catheter – Product Status 145

Percutaneous Nephrostomy Catheter – Product Description 145

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 146

Urethral Catheter – Product Status 146

Urethral Catheter – Product Description 146

University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 147

M-PED Urinary Incontinence Device – Product Status 147

M-PED Urinary Incontinence Device – Product Description 147

University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview 148

Endoscopic Laser Probe – Stress Urinary Incontinence – Product Status 148

Endoscopic Laser Probe – Stress Urinary Incontinence – Product Description 148

University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 149

Mobile Device – Urinary Incontinence – Product Status 149

Mobile Device – Urinary Incontinence – Product Description 149

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 150

Bag-less Bladder Drainage Device – Product Status 150

Bag-less Bladder Drainage Device – Product Description 150

Urethral Catheter Guidance System – Product Status 151

Urethral Catheter Guidance System – Product Description 151

University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 152

Time Sensitive Foley Catheter Alarm – Product Status 152

Time Sensitive Foley Catheter Alarm – Product Description 152

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 153

AdvanceCath Catheter – Product Status 153

AdvanceCath Catheter – Product Description 153

Urinary Assist Device – Product Status 154

Urinary Assist Device – Product Description 154

Urinary BioSolutions LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 155

Urinary Positioning Device – Product Status 155

Urinary Positioning Device – Product Description 155

UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 156

IntelliFlow System – Product Status 156

IntelliFlow System – Product Description 156

UroDev Medical – Ongoing Clinical Trials Overview 157

IntelliFlow System – Evaluation of the Safety and Clinical Performance of the Connected Catheter – Wireless Urinary Prosthesis for Management of Chronic Urinary Retention 158

Uromedica Inc Pipeline Products & Ongoing Clinical Trials Overview 159

ACT – Product Status 159

ACT – Product Description 159

Uromedica Inc – Ongoing Clinical Trials Overview 160

ACT – A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency 161

ACT – Evaluation of the Safety and Efficacy of Adjustable Continent Therapy for the Management of Neurogenic Incontinence in Children with Spinal Dysraphism 161

ACT – Prospective Study Evaluating the Safety and Effectiveness of Adjustable Continence Therapy (ACT) Balloons for the Management of Urinary Incontinence in Children with Bladder Exstrophy or Incontinent Epispadias 161

UroMems SAS Pipeline Products & Ongoing Clinical Trials Overview 162

Smart Artificial Urinary Sphincter – Product Status 162

Smart Artificial Urinary Sphincter – Product Description 162

Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 163

UroGuide – Product Status 163

UroGuide – Product Description 163

Vesiflo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164

Advanced Bladder Drainage Device – Product Status 164

Advanced Bladder Drainage Device – Product Description 164

Vysera Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 165

Urinary Incontinence Device – Product Status 165

Urinary Incontinence Device – Product Description 165

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 166

Wireless Optoelectronic System – Bladder Function – Product Status 166

Wireless Optoelectronic System – Bladder Function – Product Description 166

Watkins Conti Products Inc Pipeline Products & Ongoing Clinical Trials Overview 167

Yoni.Fit – Product Status 167

Yoni.Fit – Product Description 167

Watkins Conti Products Inc – Ongoing Clinical Trials Overview 168

Yoni.Fit – Randomized, Comparator-controlled, Single Blinded, Multi-center Study Evaluating the Efficacy and Safety of Yoni.Fit in Women with Stress Urinary Incontinence 169

Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 170

Vortex ZDS Urinary Retention Catheter – Product Status 170

Vortex ZDS Urinary Retention Catheter – Product Description 170

Glossary 275

Figures

Incontinence Devices – Pipeline Products by Stage of Development 19

Incontinence Devices – Pipeline Products by Segment 20

Incontinence Devices – Pipeline Products by Territory 21

Incontinence Devices – Pipeline Products by Regulatory Path 22

Incontinence Devices – Pipeline Products by Estimated Approval Date 23

Incontinence Devices – Ongoing Clinical Trials 24

Frequently asked questions

Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Nephrology and Urology Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more